Bioinorganic Chemistry and Applications

Bioinorganic Chemistry and Applications / 2016 / Article

Research Article | Open Access

Volume 2016 |Article ID 2691253 |

Xu-gang Shu, Chun-li Wu, Cui-jin Li, Min Zhang, Ke Wan, Xin Wu, "Synthesis, Crystal Structure, Spectroscopic Properties, and Interaction with Ct-DNA of Zn(II) with 2-Aminoethanethiol Hydrochloride Ligand", Bioinorganic Chemistry and Applications, vol. 2016, Article ID 2691253, 7 pages, 2016.

Synthesis, Crystal Structure, Spectroscopic Properties, and Interaction with Ct-DNA of Zn(II) with 2-Aminoethanethiol Hydrochloride Ligand

Academic Editor: Viktor Brabec
Received16 Nov 2015
Revised29 Dec 2015
Accepted14 Jan 2016
Published10 Feb 2016


The zinc(II) complex (C2H6NS)2Zn·ZnCl2 was synthesized with 2-aminoethanethiol hydrochloride and zinc sulfate heptahydrate as the raw materials in aqueous solution. The composition and structure of the complex were characterized by elemental analysis, infrared spectra, single crystal X-ray diffraction, and thermogravimetry. The crystal structure of the zinc(II) complex belongs to monoclinic system, space group   , with cell parameters of = 0.84294(4), = 0.83920(4), = 1.65787(8) nm, , and = 2.041 g/cm3. In this paper, the interaction of complex with Ct-DNA was investigated by UV-visible and viscosimetric techniques. Upon addition of the complex, important changes were observed in the characteristic UV-Vis bands (hyperchromism) of calf thymus DNA and some changes in specific viscosity. The experimental results showed that the complex is bound to DNA intercalative (intercalation binding).

1. Introduction

In recent years, the application of 2-aminoethanethiol hydrochloride, a cysteamine alternative, has garnered widespread attention [13]. However, cysteamine itself is not stable and easily undergoes metamorphosis due to the direct absorption of other substances. The researcher considered the fact that 2-aminoethanethiol hydrochloride structure contains NH2 and SH, which synthesize the complex of cysteamine hydrochloride with zinc(II) ions, and the complex ratio of the cysteamine hydrochloride to zinc is approximately 2 : 1 [4]. The zinc(II)-organic framework of cysteamine combined with zinc(II) ions is similar to a zinc(II) amino acid chelate, which has dual nutritional and therapeutic effects [57]. Among various microelement amino acid chelates, the complex of cysteamine with zinc(II) ions will receive more attention because of the ligand’s peculiarity in biology and widespread use in various medical treatments [813]. In the field of bioinorganic chemistry, the interaction between inorganic metal complexes and DNA has been an important area of research. In the last few years, the investigation of complex-DNA interaction is important to understand the biological activity of the complex in molecular level, indicating the interaction specificity of complex with DNA [1416]. Because the ligand of cysteamine is involved in energy transduction and it controls metabolic processes and affects the mRNA expression of BCL-2, BCL-XL, MCL-1, BAX, and BID in organisms by participating in various enzymatic reactions [12, 13], studying the interaction of complex of cysteamine combined with zinc(II) ions with DNA has vital significance.

Based on zinc sulfate heptahydrate and 2-aminoethanethiol hydrochloride as the main synthetic raw materials, zinc(II) complex was obtained by altering the reaction conditions. We report herein the X-ray single crystal structure of zinc(II) complex with cysteamine that was synthesized in chemical reactions at appropriate temperatures, and the complex ratio of the cysteamine hydrochloride to zinc is 1 : 1. Moreover, the complex was characterized by elemental analysis, Fourier transform infrared spectroscopy (FT-IR), and thermogravimetric analysis (TG), as a continuation of our research directed to study the interaction of complex and calf thymus DNA (Ct-DNA) by UV-Vis absorption and viscosity measurements to understand the molecular mechanisms of them.

2. Experimental

2.1. Materials and General Methods

All of the chemicals were of analytical reagent grade. Solutions were prepared with distilled water; highly polymerized calf thymus DNA was purchased from Sigma. The stock solution of DNA was dissolved in 0.1 M of the Tris-HCl buffer (pH 7.2) and stored at 4°C. Zinc(II) was determined by EDTA complexometric titration. The content of cysteamine in the complex was measured by iodine stoichiometry titration. FT-IR and thermogravimetric analysis were determined in the Instrumental Analysis & Research Center of Sun Yat-Sen University. The IR spectra were obtained with a Perkin-Elmer Spectrum One spectrometer in the range of 400–4000 cm−1 using KBr pellets. Thermogravimetric analysis of the metal complexes was performed on a simultaneous STA 409 PC thermal analyzer, and the measurement was recorded from 30 to 800°C at a heating rate of 10°C min−1 under air flow of 100 mL min−1. Absorbance spectra were recorded using a spectrophotometer (Lambda 950). The absorbance measurements were performed by keeping the complex concentration constant (1.744 × 10−4 mol/L) while varying the Ct-DNA concentration (from 0 to 6 × 10−5 mol/L). The samples were incubated at 37°C for 15 min, and the spectra were recorded in the range of 200–600 nm. For viscosity measurements [17], a viscosimeter (SNB-2) measured with a digital stopwatch to evaluate the viscosity of the samples. The data were reported as (/)1/3 and [Complex]/[DNA], where is the viscosity of the DNA solution alone.

2.2. Synthesis of the Compound

(C2H6NS)2Zn·ZnCl2 was synthesized by dissolving analytical grade cysteamine hydrochloride (0.02 mol, 2.27 g) with zinc sulfate heptahydrate (0.02 mol, 5.75 g) in double distilled water. The reaction pH of 6.5 was maintained by a 0.1 mol/L NaOH solution; the reaction was stirred and maintained at 90°C for 1 h. After filtration, a white powder was obtained, and the unreacted zinc sulfate heptahydrate was filtered. The products were dried at 80°C for 4 hours, and the ratio of the observed zinc(II) content with the stoichiometric amount of zinc(II) determined the yield at approximately 88.89%. Calcd. for (C2H6NS)2Zn·ZnCl2(%): Zn, 36.47; CS, 43.87. Observed (%): Zn, 35.73; cysteamine, 42.91. (C2H6NS)2Zn·ZnCl2 crystals were grown by dissolving a moderate amount of products (100 mg/mL) in a 50 mL beaker. The colorless filtrate was stored at room temperature for approximately one month, and the colorless flaky crystals of complex were obtained. The complex in polymer form was [ZnCl2Zn(u-S-CH2CH2NH2)}].

2.3. X-Ray Diffraction Crystallography

The appropriate crystals were cut from larger crystals for X-ray diffraction on a Bruker Smart 1000-CCD diffractometer with graphite monochromated Mo Kα radiation (λ = 0.71073 Å). The data were collected at 150 K. A colorless and transparent crystal with dimensions of 0.43 mm × 0.34 mm × 0.26 mm was fixed on a glass fiber. The structure was solved by direct methods (SHELXS-97) and refined by full-matrix least squares using SHELXS-97. All nonhydrogen atoms were obtained from the difference Fourier map, and full-matrix least-squares refinements on were carried out with anisotropic thermal parameters. Hydrogen atoms in the ligand were generated geometrically. The structure refinement parameters for the title complex are given in Table 1, and the crystallographic data are deposited with the Cambridge Crystallographic Data Centre under deposition number CCDC: 1010457.


Formula weight707.83
Crystal system, space groupMonoclinic, 21/
Limiting indices, ,
(all data)
Largest diff. peak and hole e/nm3688 and

3. Results and Discussion

3.1. X-Ray Crystal Structure Analysis

The single crystal X-ray diffraction analysis reveals that the complex [ZnCl2Zn(u-S-CH2CH2NH2)}] crystallises in a monoclinic system with space group 21/. Crystallographic data and structure refinement parameters for the title complex are given in Table 1, and the selected bond distances and angles are shown in Table 2. The key fragments of the structures and the atom numbering are shown in Figure 1, and the crystal packing diagram of the complex is shown in Figures 2 and 3. The crystal consisted of an asymmetric unit that is an independent part of a unit cell consisting of two Zn2+ cations, two anions, and two chlorine anions. The coordination of Zn(1) was coordinated by two donor nitrogen atoms and bidentatelly by two sulphur atoms from two anions; the coordination polyhedron of Zn(2) was coordinated by two chlorine anions and two sulphur atoms. The Zn(II) ion of the plane formed a distorted trigonal bipyramidal configuration. The Zn(II) ion was four-coordinated by two amidogen nitrogen atoms (N1, N2) and two sulphur atoms (S1, S2) from the same ligand. The structure bridged a molecular zinc chloride (Zn2, Cl1, and Cl2) through the sulphur atom of cysteamine. The bond lengths of Zn1-S1, Zn1-N1, Zn1-S2, and Zn1-N2 ranged from 0.2024 to 0.2393 nm, which is a typical distance range for zinc(II) ion complex with C and N atoms. When comparing the bond lengths of Zn-N, Zn-S, and Zn-Cl, longer bond lengths had a stronger combining capacity between nonhydrogen atoms (N, S, and Cl) and zinc ions.





Tables 2 and 3 contain one type of hydrogen bond in the crystal of the zinc(II) complex: hydrogen bonds between the crystalline amidogen and chlorine atoms (N(2)-H(2D)⋯Cl(1)1, N(1)-H(1D)⋯Cl(2)2, N(1)-H(1D)⋯Cl(1)3, N(1)-H(1D)⋯Cl(2)2) which make the structure more stable.

D-H⋯A(D-H)/nm(H⋯A)/nm(D⋯A)/nmD-H⋯A (°)


Symmetry codes: 1 = ; 2 = ; 3 = ; 4 = .
3.2. FT-IR Spectra

The FT-IR spectra of the complex are shown in Figure 5. According to the infrared spectrum of cysteamine (Figure 4), after the reaction of 2-aminoethanethiol hydrochloride with zinc salt, the product in the main absorption peak clearly changed. Under acidic conditions, the end NH2 group of cysteamine easily formed - and generated a wide absorption peak at 3000 cm−1; then the peaks observed from 2500 to 3000 cm−1 formed an ammonium band. Complex contains two narrow and medium absorption peaks at 3341 and 3269 cm−1 that were in good agreement with the N-H stretching vibration; this illustrates that NH2 in molecules participates in the coordination, and free -  does not exist. The S-H band of the ligand appears at 2507 cm−1, but the characteristic absorption peaks of the complex disappeared; the complex of cysteamine molecular ligand coordination may be consistent with zinc. According to the single crystal structure, FT-IR spectra were in good agreement with the experimental data.

3.3. Thermal Analysis

The thermal decomposition of complex can help elucidate the coordination structure of the complex. The TG curve of the complex is given in Figure 6, and the possible pyrolysis reaction and the experimental and calculated percent mass losses in the thermal decomposition process of the complex are summarized as follows (Scheme 1). The first mass loss of the compound occurred at approximately 290°C in the DG curve, suggesting that there was no crystalline water. This is consistent with the single crystal structure. Then loss at 290°C corresponds to oxidation and decomposition of the ligand. And it can be attributable to structure rearrangement or phase transformation in the solid complex. The thermal decomposition processes of the complex include oxidation and pyrolysis of the ligand, and the last residual quantity was 35.6% at temperature of 660°C.

3.4. UV-Vis

Electronic absorption spectra are initially employed to study the blinding of complex to DNA. The interaction of Zn(II) complex with Ct-DNA has been monitored in Tris-HCl (pH 7.2) buffer solutions. The concentration of the complex is a stable value with the different concentration of Ct-DNA (0–6 × 10−5 mol/L). The UV studies reveal that the interaction causes “hyperchromism effect” of DNA, but no obvious bathochromic shift occurred (Figure 7), and hyperchromism results from the damage of DNA double-helix structure [18]. According to the experimental results, we speculated that the center zinc ions directly or indirectly combine with oxygen atom of phosphoric acid in the skeleton and offense dihydrogen phosphate ester bond, but base composition is not damaged. Zinc ions have the function of Lewis acid, when they are in coordination with the oxygen in dihydrogen phosphate ester bond, causing oxygen activation, easy to fracture [18]. The literatures reported the application of cysteamine, and we studied the interaction of zinc complex with Ct-DNA which can be tuned to control its reactivity in medical science and biological applications. The experimental results showed that the complex is bound to DNA intercalative (intercalation binding).

3.5. Viscosity Measurements

Spectroscopic data are necessary but not sufficient to support intercalation binding mode. Viscosity measurements being sensitive to length change of DNA are regarded as the important method for the classical intercalation model in solution. As a means for further clarifying the binding of this complex, we studied the viscosity on DNA by varying the concentration of the added complex. As it is observed from Figure 8 in the presence of the Zn(II) complex and Ct-DNA, the data of (/)1/3 was increased with the increasing ratio of [Complex]/[DNA]. The separation of base pairs at intercalation sites and hence an increase in overall DNA length can be explained; the classical intercalation model demands that the DNA helix must lengthen as base pairs are separated to accommodate the bound ligand, leading to the increase of DNA viscosity [18].

4. Conclusions

In conclusion, new Zn(II) complex of (C2H6NS)2Zn·ZnCl2 was synthesized. The complex was investigated using several techniques, including elemental analysis, FT-IR, and TG. Thermogravimetric analysis evaluated the thermostability of the Zn(II) complex and this strategy offers a powerful tool for the preparation of Zn(II) complex with potential value in many industries. The UV hyperchromism of the absorption bands as well as the viscosity increase confirms that (C2H6NS)2Zn·ZnCl2 can strongly combine with Ct-DNA by intercalation binding.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


This work was supported by the Chinese Academy of Sciences Comprehensive Strategic Cooperation Project of Guangdong Province (2013B070704081, 2013B091500095, 2013B090900007, 2014A020208131, and KA1514966).


  1. J.-H. Jeon, H.-J. Lee, G.-Y. Jang et al., “Different inhibition characteristics of intracellular transglutaminase activity by cystamine and cysteamine,” Experimental and Molecular Medicine, vol. 36, no. 6, pp. 576–581, 2004. View at: Publisher Site | Google Scholar
  2. C. Berruyer, F. M. Martin, R. Castellano et al., “Vanin-1−/− mice exhibit a glutathione-mediated tissue resistance to oxidative stress,” Molecular and Cellular Biology, vol. 24, no. 16, pp. 7214–7224, 2004. View at: Publisher Site | Google Scholar
  3. M. Lesort, M. Lee, J. Tucholski, and G. V. W. Johnson, “Cystamine inhibits caspase activity: implications for the treatment of polyglutamine disorders,” The Journal of Biological Chemistry, vol. 278, no. 6, pp. 3825–3830, 2003. View at: Publisher Site | Google Scholar
  4. C. Wu, X. Shu, F. Chen et al., “Synthesis and property analysis of cysteamine complex with zinc(II),” Journal of Zhongkai University of Agriculture and Engineering, vol. 28, no. 3, pp. 36–39, 2015 (Chinese). View at: Google Scholar
  5. T. Balakrishnan and K. Ramamurthi, “Growth, structural, optical, thermal and mechanical properties of glycine zinc chloride single crystal,” Materials Letters, vol. 62, no. 1, pp. 65–68, 2008. View at: Publisher Site | Google Scholar
  6. T. Balakrishnan and K. Ramamurthi, “Structural, thermal and optical properties of a semiorganic nonlinear optical single crystal: glycine zinc sulphate,” Spectrochimica Acta—Part A: Molecular and Biomolecular Spectroscopy, vol. 68, no. 2, pp. 360–363, 2007. View at: Publisher Site | Google Scholar
  7. G. Predieri, D. Beltrami, R. Pattacini et al., “Structural studies in solution and in the solid state on the zinc chelate of 2-hydroxy-(4-methylthio)butanoic acid, an effective mineral supplement in animal feeding,” Inorganica Chimica Acta, vol. 362, no. 4, pp. 1115–1121, 2009. View at: Publisher Site | Google Scholar
  8. A. Kutiyanawalla, W. Promsote, A. Terry Jr., and A. Pillai, “Cysteamine treatment ameliorates alterations in GAD67 expression and spatial memory in heterozygous reeler mice,” International Journal of Neuropsychopharmacology, vol. 15, no. 8, pp. 1073–1086, 2012. View at: Publisher Site | Google Scholar
  9. A. Najafi, H. D. Kia, H. Mohammadi et al., “Different concentrations of cysteamine and ergothioneine improve microscopic and oxidative parameters in ram semen frozen with a soybean lecithin extender,” Cryobiology, vol. 69, no. 1, pp. 68–73, 2014. View at: Publisher Site | Google Scholar
  10. D. M. Okamura, N. M. Bahrami, S. Ren et al., “Cysteamine modulates oxidative stress and blocks myofibroblast activity in CKD,” Journal of the American Society of Nephrology, vol. 25, no. 1, pp. 43–54, 2014. View at: Publisher Site | Google Scholar
  11. Y. Li, X. Liu, Y. Zhang, X. Ma, and H. Lin, “Effects of cysteamine on mRNA levels of growth hormone and its receptors and growth in orange-spotted grouper (Epinephelus coioides),” Fish Physiology and Biochemistry, vol. 39, no. 3, pp. 605–613, 2013. View at: Publisher Site | Google Scholar
  12. G. Elamaran, K. P. Singh, M. K. Singh et al., “Oxygen concentration and cysteamine supplementation during in vitro production of buffalo (Bubalus bubalis) embryos affect mRNA expression of BCL-2, BCL-XL, MCL-1, BAX and BID,” Reproduction in Domestic Animals, vol. 47, no. 6, pp. 1027–1036, 2012. View at: Publisher Site | Google Scholar
  13. S.-M. Lee, E. M. Jeong, J. Jeong et al., “Cysteamine prevents the development of lens opacity in a rat model of selenite-induced cataract,” Investigative Ophthalmology & Visual Science, vol. 53, no. 3, pp. 1452–1459, 2012. View at: Publisher Site | Google Scholar
  14. H. E. Mukaya, E. W. Neuse, R. L. Van Zyl, and C. T. Chen, “Synthesis and preliminary bio-evaluation of polyaspartamide Co-conjugates of p-amino-salicylic acid chelated platinum(II) and ferrocene complexes,” Journal of Inorganic and Organometallic Polymers and Materials, vol. 25, no. 3, pp. 367–375, 2015. View at: Publisher Site | Google Scholar
  15. N. Shahabadi, S. Kashanian, K. Shalmashi, and H. Roshanfekr, “DNA interaction with PtCl2(LL) (LL = Chelating diamine ligand: N,N-dimethyltrimethylendiamine) complex,” Applied Biochemistry and Biotechnology, vol. 158, no. 1, pp. 1–10, 2009. View at: Publisher Site | Google Scholar
  16. T. Zimmermann and J. V. Burda, “Cisplatin interaction with amino acids cysteine and methionine from gas phase to solutions with constant pH,” Interdisciplinary Sciences: Computational Life Sciences, vol. 2, no. 1, pp. 98–114, 2010. View at: Publisher Site | Google Scholar
  17. M. M. Shoukry, E. M. Khairy, and A. A. El-Sherif, “Ternary complexes involving copper(II) and amino acids, peptides and DNA constituents. The kinetics of hydrolysis of α-amino acid esters,” Transition Metal Chemistry, vol. 27, no. 6, pp. 656–664, 2002. View at: Publisher Site | Google Scholar
  18. A. A. Jamali, A. Tavakoli, and J. E. N. Dolatabadi, “Analytical overview of DNA interaction with Morin and its metal complexes,” European Food Research and Technology, vol. 235, no. 3, pp. 367–373, 2012. View at: Publisher Site | Google Scholar

Copyright © 2016 Xu-gang Shu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.